How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging
European Pharmaceutical Review
OCTOBER 3, 2024
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety. Register your details to read more The post How ready are you?
Let's personalize your content